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BACKGROUND: Diabetes mellitus (DM) is associated with an accelerated atherosclerotic macrovascular disease affecting medium-sized 
arteries. Several evidences support the role of oxidative 
stress in atherogenesis. However, the role of alpha lipoic 
acid (ALA) to prevent atherosclerosis is still debatable. This 
study was conducted to determine the effect of 60 mg/kg/
day ALA for 21 days toward the expression of intercellular 
adhesion molecule-1 (ICAM-1) in rat model.
METHODS: Eighteen male rats were divided into three 
groups labelled as control group, type 2 DM (T2DM) 
group, and T2DM+ALA group. The T2DM rat models 
were created by intraperitoneally injecting 50 mg/kg 
streptozotocin,  followed by 110 mg/kg nicotinamide. 
Immunohistochemistry was used to evaluate the ICAM-
1 expression in rats. Quantitative image analysis of 
immunohistochemical stains was done on the abdominal 
aorta  using  Adobe  Photoshop  CS3  to  find  the  area 
percentage and intensity. Kruskal-Wallis and Mann-
Whitney tests were used to compare the mean value of area 
percentage and intensity. 
RESULTS: There was an increase in area percentage 
and intensity of ICAM-1 expression. The highest area 
percentage of ICAM-1 expression was found in the DM 
group, while the lowest was found in the control group. 
There were significant differences in the area percentage 
and intensity between DM+ALA group and DM group, 
where the area percentage and intensity of ICAM-I in DM 
group was higher than the DM+ALA group.
CONCLUSION: In conclusion, our results demonstrate 
that ALA inhibits the expression of ICAM-1 in T2DM rat 
models. 
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Abstract
Introduction
Diabetes mellitus (DM) is a metabolic disorder characterised 
by hyperglycemia resulting from insulin secretory 
dysfunction and/or the insulin resistance in the tissues. Type 
2 DM (T2DM), a much more prevalent category of DM, 
is caused by a combination of resistance to insulin action 
and inadequate compensatory insulin secretory response. 
Worldwidely, the number of DM prevalence had reached up 
to 285 million in 2010.(1) Based on the survey conducted by 
World Health Organization (WHO), Indonesia is the sixth 
country with the biggest DM cases in the world after China, 
India, United States, Brazil and Mexico.(2) As a chronic 
disease, DM increased the risk of developing complications. 
 Coronary heart disease (CHD) is the most common 
complication that becomes the main cause of death 
worldwide.(3) Most CHD is instigated by atherosclerosis, 
which is an inflammation process primarily regarding to 
the medium-sized arteries, such as carotid artery, coronary 
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artery, major branches of thoracic aorta, and abdominal 
aorta.(4) According to its clinical course, atherosclerosis 
is divided into several stages, including the initiation, 
progression, and complication stages.(5) At the initiation 
stage, endothelial dysfunction and activation occur because 
of increased oxidative stress and inflammation. Endothelial 
dysfunction is associated with vasorelaxant disorder due 
to the  decreased  availability  of  nitrite  oxide  (NO). 
Meanwhile, endothelial activation concerns the increase of 
nuclear factor kappa B (NF-kB) expression and adhesion 
molecules, such as E-selectin, P-selectin, vascular cell 
adhesion molecule-1 (VCAM-1) and intercellular adhesion 
molecule-1 (ICAM-1).(6) 
 Oxidative stress has an active role in the process 
of atherosclerosis. A research result of the Cholesterol 
Lowering Atherogenesis Study (CLAS) designates that 
antioxidant treatment brings a significant impact towards 
the decline of atherosclerosis process.(7) Therefore, alpha 
lipoic acid (ALA), an antioxidant likely to be developed as 
an anti-atherosclerosis agent to DM patients, has been used 
to treat diabetic neuropathy patients for 30 years, especially 
in Germany.(8) 
 Some studies disclose the potency of ALA for 
treatment in the early stages of atherosclerosis, for example 
in improving the endothelial function.(9) Administration of 
ALA for 8 weeks could restore the endothelial functions of 
DM patients, as observed from the improvement of flow-
mediated vasodilatation (FMD) and C-reactive protein 
(CRP).(10) Intravenous 600 mg ALA administration for 
21 days enables the advancement of forearm blood flow 
(FBF) in T2DM patients.(11) However, the mechanism 
underlying the effect of endothelial function restoration 
by ALA on T2DM still has not fully understood.(9) Thus, 
this experimental study was conducted to analyze the effect 
of ALA administration to T2DM rat models, specifically 
toward the ICAM-1 expression on abdominal aorta.
Methods
Research Design
An experimental study with 18 Wistar rats aged 2-3 
months and weighted 200-250 g was conducted. The rats 
were caged in a room with proper ventilation and room 
temperature of 20-26°C for 12 hours light/dark cycle. The 
rats’ health was well maintained and its cages were cleaned 
every day. All procedures were approved by the Research 
Ethics Committee, Faculty of Medicine, Universitas Riau 
(No. 211/UN.19.5.1.1.8/UEPK/201). 
The Induction of T2DM
The induction was conducted to 12-hours-fasted rats. 
The T2DM induction was completed by intraperitoneal 
injection of 50 mg/kg streptozotocin (STZ) and followed by 
intraperitoneal administration of 110 mg/kg nicotinamide 
after 15 minutes. The rat model was categorized as the 
T2DM rat model if the rat’s blood glucose level was 
>250 mg/dL after the third day of induction.(12) STZ 
was utilized for diabetes mellitus induction to the animal 
subjects for its cytotoxic effect on pancreatic β-cell, hence 
causing hyperglycemia that would raise the production of 
free radicals. Meanwhile, the nicotinamide was injected to 
reduce a defect on the pancreatic β-cell. When the STZ dose 
is given in a single low dose or multiple lower doses, the 
induction is suitable for a model of T2DM rats.(13) 
Experimental Design
The experimental rats were randomly divided into 3 groups, 
each group consisted of 6 rats. Group I was the control 
group, which consisted of the healthy rats with standard 
diet. Group II was the T2DM group, which consisted of the 
rats that have been inducted with T2DM. Meanwhile, Group 
III was the T2DM+ALA group, which consisted of T2DM 
rats which was treated with ALA. As much as 60 mg/kgBW/
day ALA treatment was given to the T2DM rats through 
nasogastric tube each day for 3 weeks.(14) 
Evaluation of Atherosclerosis
The atherosclerosis assessment was done to the abdominal 
aorta of the rats. The abdominal aorta removal was 
accomplished after the rats were anesthetized with ether 
vapor. The aortic sample was fixed with 10% formalin 
buffer for 24 hours at the room temperature. A hematoxylin 
and eosin (H&E) staining was performed to observe the 
morphological changes in the abdominal aortic in rats. 
The analysis was done under a light microscope with 
400x magnification and at 9 fields of view. Each field of 
view was counted with the following scoring scheme: 0 = 
normal; 1 = widening of elastic fibers with few foam cells; 
2 = fragmentation of elastic lamellae with numerous foam 
cells and fibrosis/calcification, vascular smooth muscle cells 
(VCMCs) proliferation, medial lipid infiltration; and 3 = 
ulcerated plaque/thrombus.(15) Score of each microscopic 
slide was tallied and the mean was measured. These 
procedures were done by the anatomic pathology specialists. 
Immunohistochemical Staining
ICAM-1 expression of tissues was examined with 
immunohistochemistry technique using the polyclonal 
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primary antibody (FineTest Company, Wuhan, China) with 
1:20 dilution. The atherosclerosis paraffin tissue without 
any addition of antibody was used as a negative control. 
The area and intensity of the staining were observed under 
a light microscope. The ICAM-1 expression was observed 
using a camera microscope with 400x magnification and 
then gauged in 10 different fields of view. Expression of 
abdominal aortic adhesion molecule was calculated by 
Adobe Photoshop CS3 (Adobe, California, USA). The 
Magic Wand tool was used to select the area containing 
ICAM-1,  meanwhile  the  Inverse  tool  was  used  to  select 
the  whole  area  of  aorta.  An optical  density  plot  of  the 
selected  area was finally quantified using the Histogram tool.
(16) The  area  percentage  was  presenting  the  comparison 
of area containing ICAM-1 to the whole section of the 
aorta, while intensity was representing the concentration 
of ICAM-1. Kruskal-Wallis and Mann-Whitney tests were 
performed to compare the mean value of area percentage 
and intensity. 
Results
The glucose levels of 12 rats in Group II and Group III that 
were induced with T2DM were >250 mg/dL. Meanwhile 
the glucose levels of the 6 rats in Group I were <250 mg/dL. 
 An  examination  of  atherosclerosis  lesion  on 
abdominal aorta was carried out using H&E staining. The 
mean score of abdominal aorta histopathological features 
was calculated based on the microscopic slide examination 
results. Table 1 showed that the mean score of Group I was 
0, Group II was 2, and Group III was 0.48±0.33. The mean 
score of Group II was significantly different to Group I, and 
also significantly different to Group III.
I 
(Control)
II 
(T2DM)
III 
(T2DM+ALA)
1 0 2 0
2 0 2 2
3 0 2 0
4 0 2 0.89
5 0 2 0
6 0 2 0
Mean 0 2a,b 0.48±0.33
Rats 
No.
Group
Table 1. Mean score of histopathological features of abdominal 
aorta.
a p<0.05: significantly different to Group I; b p<0.05: significantly 
different to Group III. Tested with Kruskal-Wallis, followed by 
Mann-Whitney analysis. 
A B C
1
2
Figure 1. Abdominal aorta microscopic examination of the three groups. A: Group I (control group); B: Group II (T2DM group); C: 
Group III (T2DM treated with ALA group); 1: smooth muscle proliferation; 2: foam cell. Black bar: 500 mm.
 Figure 1 showed the abdominal aorta microscopic 
illustration of the three groups. The Group I showed an 
intact blood vessel where thickening of tunica intima or 
foam cell were not found (Figure 1A). The thickening of 
tunica  intima,  smooth  muscle  proliferation  and  foam 
cell were merely exist in the Group II (Figure 1B). Figure 
1C  showed  that  the  microscopic  depiction  of  abdominal 
aorta in Group III, which was treated with ALA, illustrating 
the  same  abdominal  aorta  microscopic  features  as  the 
Group I.
ICAM-1 Expression
Increasing area percentage and intensity of ICAM-1 
expression was found in the media, intima and endothelium. 
The highest area percentage and intensity was found 
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in Group II, while the lowest was found in Group I. The 
ICAM-1 expression on abdominal aorta of Group II had 
a significant increase compared to Group I (p<0.05). 
On the other hand, the ICAM-1 expression of Group III 
had significant decrease compared to Group II (Table 2). 
Figure 2 also showed that the expression of ICAM-1 was 
significantly lower in Group III than in Group II, showed by 
the less Diaminobenzidine stains. 
Groups Area Percentage (%)
Intensity 
(Index) 
I (Control) 0.11±0.11 0
II (T2DM) 12.41±3.02a 34.20±7.67a
III (T2DM+ALA) 2.62±1.07b 12.21±4.41b
Table 2. ICAM-1 expression area percentage and intensity.
a p<0.05: significantly different to Group I; b p<0.05: significantly 
different to Group II. Tested with Kruskal-Wallis, followed by 
Mann-Whitney analysis. Values are presented in mean±SE.
L 
 
L L 
A B C
Figure 2. ICAM-1 immunohistochemical examination on abdominal aorta. Diaminobenzidine stains the ICAM-1 brown. A: Group 
I (control group); B: Group II (T2DM group); C: Group III (T2DM treated with ALA group); L: lumen side. Black arrows: ICAM-1 
expression; black bars: 50 µm. 
The obtained histopathological features score of all 6 
experimental rats on T2DM group were 2, which showed 
that a lesion in the form of intima thickening and smooth 
muscle proliferation were forming. When associated to the 
stages of atherosclerosis, this condition indicating that the 
experimental rats were on the progression stage.(15) The 
progression stage of atherosclerosis is characterized by the 
formation of foam cell layers and proliferation of smooth 
muscle cells.(6) 
 T2DM will induce reactive oxygen compound 
production on the vascular wall. Superoxide will react 
with nitric oxide to form peroxynitrite. This reaction will 
result in endothelial nitric oxide synthase (eNOS) going 
through uncoupling and enzyme dysfunctions, and not 
producing more nitric oxide.(17) Decreased nitric oxide 
levels stimulate an activation of NFκB (18), which is a 
gene transcription factor encoding the growth factors, 
adhesion molecules, and cytokines. The expression of 
Discussion
adhesion molecules, such as P-selectin and ICAM-1, will 
facilitate the circulating monocytes adhesion. Meanwhile, 
the interaction of monocytes cell and endothelial cell will 
cause an increased production of matrix metalloproteinase 
9 (MMP-9) in penetrating the endothelial cell. As a response 
to colony-stimulating factor, the monocytes will further 
be differentiated into macrophages, and the expression 
of various receptors like scavenger receptor and toll-
like receptors (TLRs) will occur. This scavenger receptor 
mediates the oxidized low-density lipoprotein (oxLDL) 
particle uptake by macrophages, which then instigates the 
construction of foam cells.(6) 
 In this study, the administration of 60 mg/kgBW/day 
ALA significantly decreased the formation of atherosclerotic 
lesion on T2DM rats. The atherosclerotic prevention 
towards T2DM rats can be perceived from the state of blood 
vessel that is still undamaged (intact), just like normal blood 
vessel. ALA suppresses the free radicals that are formed as 
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a result of hyperglycemia, and prevents the formation of 
vascular lesions. Compared to other similar studies, the 
doses  and  duration  of ALA treatment  in  this  study  are 
lesser. Administration of 100 mg/kgBW/day ALA for 8 
weeks could inhibit the thoracic aortic lesions of diabetic 
rats.(19) 
 The administration of 60 mg/kgBW/day ALA for 
21 days on T2DM rats has shown the effect of anti-
atherosclerotic. The result of this research is in accordance 
with a study which giving 50mg/kgBW/day ALA treatment 
to diabetic rats for 3 days each week during 3 weeks. It was 
found that ALA could significantly repair the endothelial 
function of diabetic rats given a high-fat diet.(20) The 
600 mg/kgBW/day ALA given for 21 days enables the 
improvement of endothelial function to T2DM patients.(11) 
This  research  is  also  in  line  with  another  study  showing 
that administration of 60mg/kgBW/day ALA for 2 weeks 
brings protective effect to atherosclerotic of rats treated with 
high fat diet.(14) 
 ALA is effective in many conditions where reactive 
oxygen species (ROS) have been implicated, including 
T2DM. Previous studies suggest that improved endothelial 
function due to ALA is at least partially associated with 
the recoupling of eNOS and increase of nitric oxide 
bioavailability. The mechanism of ALA anti-atherosclerotic 
effect  through  the  inhibition  of  ICAM-1  molecule 
expression is related to the ability of ALA to scavenge 
the hydroxyl radicals, singlet oxygen, hydrogen peroxide, 
hypochlorous acid, peroxynitrite and nitric oxide. Besides 
its antioxidant role, ALA also repairs the glucose uptake 
by cells and also develops the nuclear erythroid 2-related 
factor (Nrf2), which is a transcription factor regulating the 
antioxidant response.(7) 
Conclusion
This study indicates that ALA inhibits the expression of 
ICAM-1 in T2DM rat. It is suggested that ALA treatment 
may have important implication for preventing diabetic 
vascular dysfunction. 
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